导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 56.77% | 23/1050 |
| 近一周 | -1.30% | 175/1104 |
| 近一月 | -3.63% | 428/1102 |
| 近一季 | -12.97% | 781/1092 |
| 近半年 | 38.72% | 39/1070 |
| 近一年 | 74.24% | 23/1018 |
| 近两年 | 278.37% | 17/926 |
| 近三年 | 207.02% | 18/834 |
| 成立以来 | 72.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.44% 128/1070 |
95.53% 60/1101 |
- - |
- - |
| 2025 | 64.23% 84/1065 |
0.65% 748/1014 |
0.54% 647/1038 |
55.39% 55/1050 |
4.44% 155/1065 |
| 2024 | 18.17% 116/1011 |
-11.08% 800/960 |
2.17% 187/983 |
8.51% 749/991 |
19.87% 18/1011 |
| 2023 | -16.65% 586/952 |
-3.11% 749/880 |
2.77% 73/895 |
-18.02% 832/915 |
2.11% 66/952 |
| 2022 | -22.55% 425/867 |
-18.89% 462/773 |
17.23% 65/806 |
-14.17% 518/845 |
-5.10% 652/867 |
| 2021 | -2.44% 389/740 |
-8.20% 455/580 |
16.36% 214/659 |
-8.89% 476/704 |
0.25% 431/740 |
| 2020 | 64.93% 166/554 |
-0.94% 182/419 |
23.78% 215/466 |
9.06% 274/517 |
23.32% 87/554 |
| 2019 | 28.35% 299/410 |
25.60% 656/1146 |
-6.29% 795/1228 |
1.02% 307/390 |
7.95% 239/410 |
| 2018 | -25.29% 151/349 |
- - |
-6.99% 263/990 |
-6.94% 567/1000 |
-9.63% 266/1080 |
| 2017 | 20.22% 79/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.59% 110/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 信澳转型创新股票A VS. 东吴新产业精选股票A(580008) |